Stocklytics Platform

Balance Sheet

publish
A company’s balance sheet offers vital insights into its financial stability, and the Stocklytics Balance Sheet Screener gives you the tools to analyze stocks based on their key balance sheet metrics. Our screener ranks stocks by descending total assets, allowing you to focus on companies with substantial financial strength.
name
arrow_downwardASSETS PRICE $ CHANGE % CHANGE CURRENT ASSETS CASH ON HAND LIABILITIES DEBT NET DEBT EQUITY CURRENT RATIO QUICK RATIO DEBT / EQUITY
Asset logo for symbol OGEN
OGENOragenics
$2.70M$0.48$0.000.00%$1.61M$1.34M$1.38M$0.00-$1.34M$1.32M1.17-0.00AI Analysis
Asset logo for symbol LIXT
LIXTLixte Biotechnology Holdings
$2.66M$1.84-$0.16arrow_drop_down8.00%$2.66M$2.59M$421.46K$0.00-$2.59M$2.24M6.32-0.00AI Analysis
LIXT
LIXTWLixte Biotechnology Holdings
$2.66M$0.02-$0.01arrow_drop_down34.21%$2.66M$2.59M$421.46K$0.00-$2.59M$2.24M6.32-0.00AI Analysis
Asset logo for symbol VRPX
VRPXVirpax Pharmaceuticals
$2.59M$0.74-$0.01arrow_drop_down2.11%$2.59M$1.87M$5.38M$0.00-$1.87M-$2.79M0.48-0.00AI Analysis
Asset logo for symbol CNSP
CNSPCNS Pharmaceuticals
$2.46M$0.15-$0.00arrow_drop_down5.56%$2.12M$1.49M$6.76M$123.24K-$1.36M-$4.29M0.31--AI Analysis
Asset logo for symbol ASST
ASSTAsset Entities
$2.44M$1.53-$0.03arrow_drop_down1.92%$2.11M$1.92M$348.79K$0.00-$1.92M$2.09M6.05-0.00AI Analysis
Asset logo for symbol SEEL
SEELSeelos Therapeutics
$2.38M$0.20$0.000.00%$2.33M$294.00K$30.51M$10.15M$9.86M-$28.13M0.07--AI Analysis
Asset logo for symbol VCNX
VCNXVaccinex
$2.36M$4.55-$0.61arrow_drop_down11.82%$2.20M$233.00K$5.23M$122.00K-$111.00K-$2.86M0.420.42-AI Analysis
Asset logo for symbol LIPO
LIPOLipella Pharmaceuticals
$2.18M$0.42$0.03arrow_drop_up8.97%$2.08M$1.18M$480.31K$93.67K-$1.09M$1.70M4.33-0.05AI Analysis
EUDA
EUDAEuda Health Holdings Limited
$2.07M$3.48-$0.16arrow_drop_down4.39%$1.47M$320.48K$8.05M$3.37M$3.06M-$5.99M0.080.18-AI Analysis
EUDA
EUDAWEUDA Health Holdings Limited
$2.07M$0.07$0.00arrow_drop_up2.79%$1.47M$320.48K$8.05M$3.37M$3.06M-$5.99M0.080.18-AI Analysis
NLSP
NLSPWNLS Pharmaceutics AG
$1.84M$0.01$0.00arrow_drop_up90.00%$1.82M$897.68K$10.68M$1.63M$736.06K-$8.83M0.23--AI Analysis
Asset logo for symbol NLSP
NLSPNLS Pharmaceutics AG
$1.84M$0.13-$0.00arrow_drop_down0.07%$1.82M$897.68K$10.68M$1.63M$736.06K-$8.83M0.23--AI Analysis
Asset logo for symbol VS
VSVersus Systems
$1.83M$1.24-$0.07arrow_drop_down5.35%$1.82M$905.91K$32.93K$0.00-$905.91K$9.51M55.55-0.00AI Analysis
Asset logo for symbol ALZN
ALZNAlzamend Neuro
$1.66M$1.75$0.02arrow_drop_up1.15%$1.41M$1.19M$2.88M$300.71K-$1.19M-$1.21M0.14--AI Analysis
Asset logo for symbol NXLIW
NXLIWNexalin Technology
$1.56M$0.10-$0.01arrow_drop_down10.95%$1.18M$848.79K$212.10K$0.00-$848.79K$1.35M5.574.880.00AI Analysis
Asset logo for symbol NXL
NXLNexalin Technology
$1.56M$0.70$0.03arrow_drop_up5.81%$1.18M$848.79K$212.10K$0.00-$848.79K$1.35M5.574.880.00AI Analysis
Asset logo for symbol PTIX
PTIXProtagenic Therapeutics
$1.46M$0.59-$0.03arrow_drop_down5.11%$1.36M$924.59K$674.55K$0.00-$924.59K$792.51K2.02-0.00AI Analysis
Asset logo for symbol NRSN
NRSNNeuroSense Therapeutics Ltd.
$1.44M$1.35$0.000.00%$1.19M$771.00K$8.43M$55.00K-$716.00K-$6.99M0.260.36-AI Analysis
NRSN
NRSNWNeuroSense Therapeutics Ltd.
$1.44M$0.17$0.01arrow_drop_up6.25%$1.19M$771.00K$8.43M$55.00K-$716.00K-$6.99M0.260.36-AI Analysis
Showing 4881-4900 of 4977
Results per page:

A company’s balance sheet offers vital insights into its financial stability, and the Stocklytics Balance Sheet Screener gives you the tools to analyze stocks based on their key balance sheet metrics. Our screener ranks stocks by descending total assets, allowing you to focus on companies with substantial financial strength. In addition to total assets, the screener provides critical balance sheet details: - Current Assets – View a company’s liquid assets and those expected to be converted into cash within a year. - Cash on Hand – Evaluate a company’s cash reserves, a key indicator of liquidity and financial flexibility. - Liabilities – Examine both short-term and long-term obligations, providing insights into a company’s financial commitments. - Debt – Get a breakdown of a company’s debt levels, including the impact of borrowing on its financial structure. - Net Debt – See the company’s total debt minus its cash on hand for a clearer picture of its actual debt burden. - Equity – Review the value of shareholder equity to understand the company’s financial foundation. - Current Ratio – Measure a company’s ability to cover short-term obligations with its current assets. - Quick Ratio – Analyze a company’s liquidity by excluding inventory from current assets, focusing on more readily available resources. - Debt/Equity Ratio – Assess how leveraged a company is by comparing its total debt to shareholder equity. - The Stocklytics Balance Sheet Screener gives you all the data needed to evaluate a company's financial health at a glance, allowing you to focus on metrics that matter most for assessing long-term stability. Why Use the Balance Sheet Screener? - Financial Strength: Identify companies with strong balance sheets, essential for long-term investment. - Liquidity: Focus on firms with high liquidity ratios for safer investments. - Leverage: Understand a company's debt load and its impact on future profitability.
toolkit image

Discover the Power of Stocklytics Tools

Our suite of tools empowers you to make informed decisions, seize opportunities, and stay ahead in the competitive trading world.

See Stocklytics Tools

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level